Last updated on February 2017

Safety Tolerability PK and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides


Brief description of study

The purpose is to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of IONIS APOC-III-LRx given to healthy volunteer subjects.

Clinical Study Identifier: NCT02900027

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Dara Bacanek

BioPharma Services
Toronto, ON Canada
  Connect »